The interferon system in multiple sclerosis: Towards a personalized medicine approach for IFNβ therapy

C.L. Verweij; S. Vosslamber

The interferon system in multiple sclerosis: Towards a personalized medicine approach for IFNβ therapy

C.L. Verweij, S. Vosslamber

Pathology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

Original language	Undefined/Unknown
Title of host publication	Type I Interferons, Mechanism of Action, Implications in Inflammatory and Autoimmune Diseases and Clinical Applications
Place of Publication	New York
Publisher	NOVA Science publishers, Inc.
Publication status	Published - 2012

Cite this

@inbook{841fe031031440e08557113e84fa6219,

title = "The interferon system in multiple sclerosis: Towards a personalized medicine approach for IFNβ therapy",

author = "C.L. Verweij and S. Vosslamber",

year = "2012",

language = "Undefined/Unknown",

booktitle = "Type I Interferons, Mechanism of Action, Implications in Inflammatory and Autoimmune Diseases and Clinical Applications",

publisher = "NOVA Science publishers, Inc.",

}

The interferon system in multiple sclerosis: Towards a personalized medicine approach for IFNβ therapy. / Verweij, C.L.; Vosslamber, S.

Type I Interferons, Mechanism of Action, Implications in Inflammatory and Autoimmune Diseases and Clinical Applications. New York : NOVA Science publishers, Inc., 2012.

Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

TY - CHAP

T1 - The interferon system in multiple sclerosis: Towards a personalized medicine approach for IFNβ therapy

AU - Verweij, C.L.

AU - Vosslamber, S.

PY - 2012

Y1 - 2012

M3 - Chapter

BT - Type I Interferons, Mechanism of Action, Implications in Inflammatory and Autoimmune Diseases and Clinical Applications

PB - NOVA Science publishers, Inc.

CY - New York

ER -